DNMT3A and myelodysplastic syndrome: Furthermore, there is also a coherence between DNMT3A mutations and patients with myelodysplastic syndrome (MDS), since Walter et al. described the frequency of DNMT3A mutations in patients with de novo MDS and their association with secondary AML[27].